These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25272295)

  • 1. Uterine fibroids: do we deal with more than one disease?
    Markowski DN; Helmke BM; Bartnitzke S; Löning T; Bullerdiek J
    Int J Gynecol Pathol; 2014 Nov; 33(6):568-72. PubMed ID: 25272295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.
    Markowski DN; Bartnitzke S; Löning T; Drieschner N; Helmke BM; Bullerdiek J
    Int J Cancer; 2012 Oct; 131(7):1528-36. PubMed ID: 22223266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.
    Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ
    Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
    Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
    Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
    Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
    Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
    Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
    Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
    Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
    PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
    Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
    Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution.
    Moravek MB; Bulun SE
    Curr Opin Obstet Gynecol; 2015 Aug; 27(4):276-83. PubMed ID: 26107781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations in uterine fibroids - a new direction for pharmacological intervention?
    Markowski DN; Holzmann C; Bullerdiek J
    Expert Opin Ther Targets; 2015; 19(11):1485-94. PubMed ID: 26293838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
    Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS
    Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.
    Mäkinen N; Mehine M; Tolvanen J; Kaasinen E; Li Y; Lehtonen HJ; Gentile M; Yan J; Enge M; Taipale M; Aavikko M; Katainen R; Virolainen E; Böhling T; Koski TA; Launonen V; Sjöberg J; Taipale J; Vahteristo P; Aaltonen LA
    Science; 2011 Oct; 334(6053):252-5. PubMed ID: 21868628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cultures in uterine leiomyomas: rapid disappearance of cells carrying MED12 mutations.
    Nadine Markowski D; Tadayyon M; Bartnitzke S; Belge G; Maria Helmke B; Bullerdiek J
    Genes Chromosomes Cancer; 2014 Apr; 53(4):317-23. PubMed ID: 24446130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
    de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
    Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular matrix (ECM) activates β-catenin signaling in uterine fibroids.
    Ko YA; Jamaluddin MFB; Adebayo M; Bajwa P; Scott RJ; Dharmarajan AM; Nahar P; Tanwar PS
    Reproduction; 2018 Jan; 155(1):61-71. PubMed ID: 29066531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA proteins regulate the expression of FGF2 in uterine fibroids.
    Helmke BM; Markowski DN; Müller MH; Sommer A; Müller J; Möller C; Bullerdiek J
    Mol Hum Reprod; 2011 Feb; 17(2):135-42. PubMed ID: 20926602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED12 and uterine smooth muscle oncogenesis: State of the art and perspectives.
    Croce S; Chibon F
    Eur J Cancer; 2015 Aug; 51(12):1603-10. PubMed ID: 26037152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.